Chris’s practice focuses on complex civil litigation and government investigations. Chris has particular experience with competition-related matters, having handled a range of disputes involving antitrust and intellectual property. Chris has represented clients across a variety of industries, including companies in the life sciences, technology, and media sectors.
Representative Experience
Though all cases vary and none is predictive, Chris’s experience includes:
- Representations of Google in a monopolization case brought by the U.S. Department of Justice and various state attorneys general.
- Representation of AstraZeneca in a Hatch-Waxman patent matter relating to the anti-cancer medication, Tagrisso®.
- Representation of Pfizer in a patent-infringement matter relating to the COVID-19 antiviral therapy, Paxlovid™.
- Representation of an iconic media company in a confidential arbitration relating to a trademark-licensing dispute, resulting in an across-the-board judgment in favor of the client with attorneys’ fees awarded.
- Representation of several pharmaceutical companies in a variety of matters defending so-called “reverse payment” patent settlements from antitrust attack.
- Representation of Bayer, LEO Pharma, and Foamix Pharmaceuticals in Hatch-Waxman patent litigation involving Finacea® Foam.
- Representation of a global biopharmaceutical company in connection with an alleged breach of contract relating to a collaboration and license agreement.